From L-R: COO David Shoultz, CEO Daniel-Adriano Silva and CSO Alfredo Quijano Rubio (Monod Bio)

David Bak­er lab spin­out scores seed fund­ing to build a biosen­sor from en­gi­neered pro­tein

Af­ter em­bark­ing on the jour­ney of co-found­ing a biotech, Daniel-Adri­ano Sil­va was in search of his next mis­sion. He vis­it­ed David Bak­er’s lab­o­ra­to­ry at the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.